Efficacy of Daily vs Weekly Levothyroxine for Hypothyroidism

Efficacy of Daily vs Weekly Levothyroxine for Hypothyroidism

Researchers examined the safety and efficacy of daily vs weekly levothyroxine therapy for hypothyroidism in young and middle aged adults.

TSH Lab Results With Brand vs Generic Levothyroxine

TSH Lab Results With Brand vs Generic Levothyroxine

Synthroid was associated with an 11% lower likelihood of having out-of-range TSH lab values vs generic levothyroxine.

Case Study: Adverse Cerebrovascular Event With Testosterone Use

Case Study: Adverse Cerebrovascular Event With Testosterone Use

A 28-year-old male patient, otherwise in good health, presented with acute onset vertigo, nausea, and vomiting resulting from exogenous testosterone use.

Does Vitamin D Supplementation Affect Subclinical Hypothyroidism

Does Vitamin D Supplementation Affect Subclinical Hypothyroidism

Researchers noted a significant increase in serum vitamin D and significant reductions in TSH following 3 months of vitamin D supplementation.

Effect of Highly Active Antiretroviral Therapy on BMI in HIV

Effect of Highly Active Antiretroviral Therapy on BMI in HIV

Patients on HAART may require additional metabolic monitoring for cardiovascular issues.

Adherence to Topical Testosterone Therapy in Primary and Secondary Hypogonadism

Adherence to Topical Testosterone Therapy in Primary and Secondary Hypogonadism

Low adherence to topical testosterone therapy has been linked to lowered total testosterone values and poor outcomes.

Case Study: How Can Dietary Supplement Use Lead to Thyroid Disease?

Case Study: How Can Dietary Supplement Use Lead to Thyroid Disease?

A patient presented with intentional 10-pound weight loss, suppressed thyroid-stimulating hormone, and increased FT4 and TT3 levels.

Severe Adrenal Deficiency With Topical Steroid Application for Psoriasis

Severe Adrenal Deficiency With Topical Steroid Application for Psoriasis

The patient presented with symptoms consistent with adrenal deficiency following 18 years of topical steroid application.

Liraglutide Plus Metformin Leads to Remission in New-Onset Type 2 Diabetes

Liraglutide Plus Metformin Leads to Remission in New-Onset Type 2 Diabetes

The combined treatment regimen of metformin and liraglutide led to complete remission in 74% of patients with new onset type 2 diabetes.

Lower HbA1c Reached With Combined Empagliflozin/Linagliptin vs Monotherapy

Lower HbA1c Reached With Combined Empagliflozin/Linagliptin vs Monotherapy

More patients receiving empagliflozin and linagliptin combination therapy were able to reach HbA1c goals compared with those patients receiving monotherapy.

Upcoming Meetings

Sign Up for Free e-Newsletters